Last viewed: HGEN

Prices are updated after-hours

HGEN

Humanigen, Inc.

HGEN | $0.0361 -61.5% 120M

|

Health Technology

(0.0% 1d) (0.0% 1m) (-80.1% 1y) (0.0% 2d) (0.0% 3d) (-81.1% 7d) (23283.32% volume)
Earnings Calendar: 2022-11-09
Market Cap: $ 4,298,793
http://www.humanigen.com
Sec Filling | Patents | 2 employees

(US) Humanigen, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of cell and gene therapies for the treatment of cancers through novel human granulocyte-macrophage colony-stimulating factor neutralization and gene-knockout platforms. The company was founded by Jeng-Horng Her & Robert F. Balint on March 15, 2000 and is headquartered in Burlingame, CA.

cancer gene therapies t-cell treatment ceiling

add to watch list Paper trade email alert is off

Press-releases

Carisma Therapeutics Announces Changes to its Board of Directors
Published: 2024-04-01 (Crawled : 11:00) - prnewswire.com
NVS | $92.57 -0.55% 0.27% 840K

|

Health Technology

| -3.42% | O: 0.47% H: 0.23% C: -0.99%
CRIS | $15.22 -4.58% -6.62% 20K

|

Health Technology

| 41.72% | O: 0.7% H: 16.87% C: 16.87%
therapeutics

Delisting of Securities of Humanigen, Inc.; Vinco Ventures, Inc.; Liquid Media Group Ltd.; Republic First Bancorp, Inc.; G Medical Innovations Holdings Ltd.; Orbital Infrastructure Group, Inc.; Spark Networks SE; DIRTT Environmental Solutions Ltd.; Chenghe Acquisition Co.; mCloud Technologies Corp.; VIQ Solutions Inc.; Capstone Green Energy Corporation; and Histogen Inc. from The Nasdaq Stock Market
Published: 2023-10-11 (Crawled : 20:00) - globenewswire.com
VQSSF | $0.1536 -4.6% -17.76% 6.4K

|

| -23.08% | O: -0.77% H: 18.86% C: 2.33%
CGRNQ A | $0.21 46.43% 5.7K

|

| -30.23% | O: 0.33% H: 7.38% C: 4.17%
DRTTF | $0.485 2.28% 0.0% 3.3K

|

| 18.38% | O: -5.0% H: 0.25% C: 0.25%
GMVDF | $0.02 33.33% 0% 4.2K

|

| -66.22% | O: 7.43% H: 16.35% C: -5.35%
MCLDF | $0.0002 100.0% 1919900.0% 25

|

Technology Services

| -99.89% | O: -99.46% H: 0.0% C: 0.0%
FRBK 4 | $0.0116 -61.33% 280.95% 21K

|

| -76.92% | O: 0.0% H: 53.85% C: 0.0%
NDAQ | $60.07 0.1% 0.11% 2M

|

| 20.84% | O: 0.12% H: 0.46% C: -0.8%
HSTO | News | $0.5 67.46% 530

|

Health Technology

| -41.86% | O: 1.16% H: 6.9% C: -3.45%
FBNC | $31.26 0.9% 0.9% 170K

|

| 10.08% | O: 0.32% H: 0.0% C: -1.12%
media energy group acquisition solutions medical market

Humanigen Announces First Participant Dosed in RATinG Trial of Lenzilumab for Early Treatment of Acute Graft Versus Host Disease Following Allogeneic Stem Cell Transplantation
Published: 2023-08-07 (Crawled : 15:00) - biospace.com/
HGEN | $0.0361 -61.5% 120M

|

Health Technology

| Email alert Add to watchlist
disease cell treatment lenzilumab trial

Humanigen - Lenzilumab Being Studied as a Potential First Treatment in Thirty Years with a Novel Mechanism of Action for Chronic Myelomonocytic Leukemia (CMML), an Orphan Form of Leukemia
Published: 2023-04-14 (Crawled : 19:00) - biospace.com/
HGEN | $0.0361 -61.5% 120M

|

Health Technology

| -73.86% | O: -3.69% H: 36.84% C: 24.44%
treatment lenzilumab leukemia potential

Humanigen Reports Third Quarter 2022 Financial Results
Published: 2022-11-15 (Crawled : 15:00) - biospace.com/
HGEN | $0.0361 -61.5% 120M

|

Health Technology

| -77.87% | O: 3.0% H: 3.57% C: 0.42%
financial results

Humanigen Announces Participation and Presentation at Jefferies London Healthcare Conference
Published: 2022-11-10 (Crawled : 15:00) - biospace.com/
HGEN | $0.0361 -61.5% 120M

|

Health Technology

| -72.59% | O: 3.26% H: 6.62% C: 2.94%
conference presentation

Humanigen Announces Retention of SC&H Capital as Financial Advisor
Published: 2022-10-31 (Crawled : 14:00) - biospace.com/
HGEN | $0.0361 -61.5% 120M

|

Health Technology

| -75.1% | O: 3.45% H: 4.67% C: -6.6%
financial

Movers & Shakers: Adaptive Phage, Atossa, Nimbus and more
Published: 2022-10-28 (Crawled : 13:20) - biospace.com/
BFRI | $1.67 -2.34% -0.59% 41K

|

| -91.73% | O: -0.91% H: 1.83% C: -1.83%
JNJ | News | $145.74 0.67% -0.18% 7M

|

Health Technology

| -15.88% | O: 1.31% H: 0.0% C: 0.0%
XFOR | $1.2 0.42% 0.0% 1.6M

|

Health Technology

| -39.39% | O: 2.02% H: 0.0% C: -3.47%
SCYX | $1.405 -1.06% 3.4% 80K

|

Health Technology

| -41.56% | O: 0.0% H: 2.05% C: -0.41%
LUNG | $7.5 0.94% 0.93% 540K

|

Health Technology

| -45.53% | O: -0.07% H: 0.44% C: -0.95%
OPT | $3.4 0.29% 2.7K

|

Health Technology

| -34.74% | O: -6.91% H: 0.0% C: 0.0%
HGEN | $0.0361 -61.5% 120M

|

Health Technology

| -75.03% | O: 1.73% H: 1.97% C: -1.43%
DBVT | $0.661 -2.79% -2.87% 19K

|

Health Technology

| -57.14% | O: 1.95% H: 1.64% C: 0.0%
ATHX | $0.1018 -40.86% 95M

|

Health Technology

| -95.54% | O: 1.36% H: 13.9% C: 13.45%

DBV Technologies Announces Appointment of New Chair of its Audit Committee and Appointment of Daniele Guyot-Caparros to Board of Directors
Published: 2022-10-03 (Crawled : 21:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K

|

Health Technology

| 21.72% | O: 8.97% H: 0.0% C: 0.0%
SNY | News | $45.39 -1.56% -1.58% 4.3M

|

Health Technology

| 17.69% | O: 2.72% H: 0.0% C: 0.0%
HGEN | $0.0361 -61.5% 120M

|

Health Technology

| -79.72% | O: 20.0% H: 21.11% C: -5.48%
DBVT | $0.661 -2.79% -2.87% 19K

|

Health Technology

| -62.92% | O: 2.25% H: 1.24% C: -1.1%
AQST | $4.5 14.8% 12.99% 5.6M

|

Health Technology

| 281.36% | O: 1.69% H: 2.5% C: -5.0%

KRBP TUESDAY DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Kiromic BioPharma, Inc. Investors With Losses to Secure Counsel Before Important October 4 Deadline in Securities Class Action - KRBP
Published: 2022-09-30 (Crawled : 20:00) - prnewswire.com
HGEN | $0.0361 -61.5% 120M

|

Health Technology

| Email alert Add to watchlist
KRBP | $2.5 8.7% -90.21% 830

|

Health Technology

| Email alert Add to watchlist
deadline

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001013594-23-000819	4	2023-10-20	2023-10-18	Sell	S	276210	8398871
0001013594-23-000819	4	2023-10-20	2023-10-18	Sell	S	75887	2307530
0001013594-23-000819	4	2023-10-20	2023-10-18	Sell	S	34253	1041536

Your Today's Watch List

Sign in to create a watchlist

Gainers vs Losers

59%

41%

Top 10 Gainers

AGBA | News | $1.03 157.5% 57.94% 120M

|

ZCMD | $1.45 5.84% 52.1% 2.3M

|

Commercial Services

INVO | $1.52 100.0% 51.13% 5M

|

Health Technology

ISPC | $0.421 97.65% 49.53% 37M

|

Professional, Scientific, and T...

WLGS | News | $0.5 45.65% 470K

|

OST | $0.509 23.81% 45.26% 90K

|

GDHG | $0.263 21.76% 40.66% 3.1M

|

XPON | News | $3.15 63.21% 37.74% 16M

|

TIRX | $0.8 65.02% 30.74% 58M

|

BNTC | News | $6.82 42.08% 30.64% 3.5M

|

Health Technology

Last 48 Hours Insiders Buying

ADMQ | $0.0532 -4.14% -40.18% 480K

|

| 10:30
AXR P 2400 | $22.17 2.69% 0.0% 5.5K

|

| 21:00
QCRH P 118 | $55.41 1.34% 1.31% 54K

|

| 18:01
VUZI P 7500 | $1.26 3.28% 3.17% 930K

|

Electronic Technology

| 18:00
RMCF | $3.5501 0.57% 2.22% 18K

|

Consumer Non-Durables

| 20:10

12 months watchlist earnings calendar